Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom
暂无分享,去创建一个
[1] E. Azziz-Baumgartner,et al. Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season — Chile, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[2] E. Lau,et al. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study , 2022, The Lancet Global Health.
[3] J. Paget,et al. Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines? , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[4] C. Macintyre,et al. Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] C. Macintyre,et al. Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia , 2021, Influenza and other respiratory viruses.
[6] B. Cowling,et al. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination , 2021, Nature Communications.
[7] L. Coudeville,et al. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study , 2021, PloS one.
[8] S. Majumdar,et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) , 2021, Nature Human Behaviour.
[9] A. Chit,et al. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry , 2020, Vaccine.
[10] Seattle,et al. Inferring high-resolution human mixing patterns for disease modeling , 2020, Nature communications.
[11] L. Brammer,et al. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century , 2019, PloS one.
[12] Wladimir J Alonso,et al. The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe? , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] E. Clay,et al. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe , 2016, Human vaccines & immunotherapeutics.
[14] Pascal Crépey,et al. Retrospective public health impact of a quadrivalent influenza vaccine in the United States , 2015, Influenza and other respiratory viruses.
[15] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[16] L. Kramer,et al. Perspective of the Pharmaceutical Industry , 1990 .